Memic Innovative Surgery to go public via a SPAC merger with MedTech Acquisition in a $1bn deal.

Memic Innovative Surgery, a medical device company, agreed to go public via a SPAC merger with MedTech Acquisition in a $1bn deal. The transaction includes a $76m PIPE from Bridger Healthcare, The Kraft Group, Monashee Investment Management, Pura Vida Investments, Wellington Management, Ken Langone, Peregrine Ventures, HighSage Ventures and MedTech's management. The business combination is expected to be completed in the fourth quarter of 2021. "Our partnership with the MedTech team, which provides decades of collective experience in surgical robotics, is an important step in bringing our advanced technology to medical facilities and patients across the United States and the world. We look forward to entering the public markets and working together with MedTech in the next phase of our company's journey," Dvir Cohen, Memic Co-Founder and CEO.